J 2023

Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature

GONZALEZ-RIVAS, Juan P., Iuliia PAVLOVSKA, Anna POLCROVÁ, Ramfis NIETO-MARTINEZ, Jeffrey I. MECHANICK et. al.

Basic information

Original name

Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature

Authors

GONZALEZ-RIVAS, Juan P. (guarantor), Iuliia PAVLOVSKA (804 Ukraine, belonging to the institution), Anna POLCROVÁ (203 Czech Republic, belonging to the institution), Ramfis NIETO-MARTINEZ and Jeffrey I. MECHANICK

Edition

AMERICAN JOURNAL OF LIFESTYLE MEDICINE, THOUSAND OAKS, SAGE PUBLICATIONS INC, 2023, 1559-8276

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.900 in 2022

RIV identification code

RIV/00216224:14110/23:00130012

Organization unit

Faculty of Medicine

DOI

UT WoS

000806385700001

Keywords in English

dysglycemia; culture; lifestyle medicine; prevention; transcultural; type 2 diabetes

Tags

Tags

International impact, Reviewed
Změněno: 26/1/2024 10:10, Mgr. Tereza Miškechová

Abstract

V originále

Disparities in type 2 diabetes (T2D) care is a global problem across diverse cultures. The Dysglycemia-Based Chronic Disease (DBCD) model promotes early and sustainable interventions along the insulin resistance (stage 1), prediabetes (stage 2), T2D (stage 3), and complications (stage 4) spectrum. In this model, lifestyle medicine is the cornerstone of preventive care to reduce DBCD progression and the socioeconomic/biological burden of disease. A comprehensive literature review, spanning 2000 to 2021, was performed and 55 studies were included examining the effects of lifestyle medicine and their cultural adaptions with different prevention modalities. In stage 1, primordial prevention targets modifiable primary drivers (behavior and environment), unhealthy lifestyles, abnormal adiposity, and insulin resistance with educational and motivational health promotion activities at individual, group, community, and population-based scales. Primary, secondary, and tertiary prevention targets individuals with mild hyperglycemia, severe hyperglycemia, and complications, respectively, using programs that incorporate structured lifestyle interventions. Culturally adapted lifestyle change in primary and secondary prevention improved quality of life and biomarkers, but with a limited impact of tertiary prevention on cardiovascular events. In conclusion, lifestyle medicine with cultural adaptations is an integral part of preventive care in patients with T2D. However, considerable research gaps exist, especially for tertiary prevention.